Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based H. pylori eradication therapy in hemodialysis patients
jRCTs031200237Recruiting
- Sponsor
- Yokohama City University
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vonoprazan, amoxicillin and clarithromycin in Helicobacter pylori infection, sponsored by Yokohama City University. Primary endpoint: Eradication rate (PPS). Started May 2023; status: recruiting.
02
Drugs
vonoprazanamoxicillinclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on jRCTs031200237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200237.